Sub menu

 
 

Extension to the shortage of Vyvanse 60mg (lisdexamfetamine dimesilate) capsules

Published

Takeda Pharmaceuticals Australia has notified us that the shortage of Vyvanse 60 mg capsules will be extended until 30 April 2024. The shortage of Vyvanse 40 mg is also expected to resolve on 30 April 2024.

The shortages of Vyvanse 30 mg and 50 mg have resolved and supply has returned to normal. 

The most up-to-date information about these shortages is published on the Medicine Shortage Reports Database. 

Important information for patients, carers, pharmacists and prescribers is available at About the shortage of Vyvanse (lisdexamfetamine dimesilate) capsules.

Topics

This webpage on the TGA website was printed on 10 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/extension-shortage-vyvanse-60mg-lisdexamfetamine-dimesilate-capsules

Help us improve the Therapeutic Goods Administration site